Stay updated on Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedUpdated the page revision from v3.5.3 to v3.5.4, indicating a minor update to the study page content and its tracking version.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe revision indicator changed from v3.5.2 to v3.5.3. This reflects a new build/update of the site and does not modify the study details displayed on the page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. No changes to the study details or navigation are evident.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded a Revision: v3.4.3 label and removed the Revision: v3.4.2 label from the page; the change affects only metadata and does not alter study content or data.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision updated to v3.4.2; the operating-status notice and the prior revision note (v3.4.1) were removed.SummaryDifference0.4%

Stay in the know with updates to Epacadostat + Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Durvalumab in Solid Tumors Clinical Trial page.